तुलना करने के लिए मीट्रिक्स | CONB | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधCONBपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 55.0x | 30.5x | −0.4x | |
PEG अनुपात | −2.40 | 0.34 | 0.00 | |
क़ीमत/बुक | 7.5x | 4.4x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 13.7x | 3.8x | 3.1x | |
अपसाइड (विश्लेषक लक्ष्य) | 9.8% | 7.4% | 49.6% | |
उचित मूल्य अपसाइड | अनलॉक करें | 2.2% | 7.1% | अनलॉक करें |
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsirolimus, everolimus, romidepsin, doxorubicin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment. In addition, the company provides mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, and nystatin for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. Further, it develops daptomycin for anti-infectives applications; and epirubicin, idarubicin, and pirarubicin for oncology therapeutic segment. Additionally, the company provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.